1 The retractions came only a few months after BioMed Central.

This pressure exists almost but is specially intense in China everywhere. It is therefore no real surprise that the many inventive ways to video game the peer-review program to get manuscripts published attended from China. The firms mentioned above that provide fake peer reviews all come from countries and China in Southeast Asia, & most of the authors involved in these full cases result from the same areas. But it would be a mistake to check out this as a Chinese or Asian problem. The problem is the perverse incentive systems in scientific publishing. As long as authors are rewarded for publishing many content articles and editors are rewarded for publishing them quickly, new ways of gaming the traditional publication versions will be invented quicker than new control procedures could be put in place..The New York cohort included 40 controls with effusions not because of mesothelioma. Of these patients, 2 got an asbestos-related inflammatory effusion, 4 had chronic inflammation, 1 got congestive heart failing, 7 got a reactive pleural effusion, 7 acquired adenocarcinoma of the lung, 2 had squamous carcinoma of the lung, 3 had lung cancer not really otherwise specified, 3 had gastrointestinal adenocarcinoma, 1 had renal-cell malignancy, 1 had sarcoma, 1 had cancers of an unknown main site, 5 had breasts cancer, 2 got small-cell carcinoma, and 1 had lymphoma. Matching plasma samples were obtainable from 30 of the 40 handles in the brand new York cohort.